New research suggests Transcatheter Aortic-Valve Replacement (TAVR) may benefit patients with asymptomatic severe aortic stenosis, challenging traditional treatment timing. This study explores its potential to improve outcomes and reshape guidelines. Read more to see how early intervention could impact patient care.
A recent study in the New England Journal of Medicine examines the efficacy of transcatheter tricuspid-valve replacement in patients with severe tricuspid regurgitation. The findings suggest that this minimally invasive procedure may offer a promising alternative to traditional surgical approaches.
The RHEIA trial is the first randomised study focusing exclusively on women with severe symptomatic aortic stenosis. It found that transcatheter aortic valve implantation (TAVI) was superior to surgical valve replacement in reducing death, stroke, and rehospitalisation at one year.
A recent New England Journal of Medicine study evaluated transcatheter mitral-valve repair in heart failure patients with moderate to severe mitral regurgitation. Results showed a reduction in hospitalisations and cardiovascular deaths, suggesting this minimally invasive approach may benefits over traditional treatments.
Decision-making in VHD involves accurate diagnosis, timing of intervention, risk assessment and, based on these, selection of the most suitable type of intervention. These guidelines focus on acquired VHD and its management. This guideline will be updated in 2025
The current guidelines have been developed to support healthcare professionals with the diagnosis and management of patients with infective endocarditis. There have been multiple developments in the care of patients with infective endocarditis. This document should serve as a guide for clinicians involved in the diagnosis and management of infective endocarditis patients and should lead to improved outcomes for this serious disease.
AortiCare is an innovative educational programme co-organised by ESC and ACNAP, designed to support primary care professionals, general cardiologists, interventionalists and nurses in the timely diagnosis, referral, and management of patients with aortic stenosis, a condition affecting over 12% of Europeans over 75.
AortiCare addresses key challenges healthcare professionals face in the care of patients with aortic stenosis. By providing you with cutting-edge knowledge and resources, AortiCare aims to improve the care pathway and patient outcomes.
Resources include: webinars, e-learning module and toolkit.
This elearning programme was developed to support health and care professionals from a range of multidisciplinary backgrounds, in better understanding heart failure and heart valve disease. It is targeted at clinicians in primary and community care settings, including GPs.
Despite recommendations in several valvular heart disease clinical guidelines across the globe, too often, people living with heart valve disease (HVD) are still not being optimally involved in conversations about their treatment options and preferences.
Global areas of focus:
Heart Valve Voice is the UK’s dedicated heart valve disease charity working to help increase the awareness of heart valve disease in the UK and improve diagnosis and treatment